[The use of diethylaminoethyl-dextran (DEAE-D) as adjuvant for immunization of guinea pigs with inactivated foot-and-mouth disease (FMD) virus].
D000276:Adjuvants, Immunologic; D000464:Alginates / Q000494:pharmacology; D000818:Animals; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D005537:Aphthovirus / Q000276:immunology*; D003911:Dextrans / Q000494:pharmacology*; D005536:Foot-and-Mouth Disease / Q000517:prevention & control; D005620:Freund's Adjuvant; D006168:Guinea Pigs; D007273:Injections, Intramuscular; D051379:Mice; D009500:Neutralization Tests; D013501:Surface-Active Agents / Q000494:pharmacology; D014611:Vaccination; D014765:Viral Vaccines / Q000008:administration & dosage*
D000276:Adjuvants, Immunologic; D000464:Alginates; D000906:Antibodies; D003911:Dextrans; D013501:Surface-Active Agents; D014765:Viral Vaccines; D005620:Freund's Adjuvant
Die Verwendung von Diathylaminoaethyl-Dextran (DEAE-D) als Adjuvans bei der Immunisierung von Meerschweinchen mit inaktiviertem Maul- und Klauenseuche (MKS)-Virus.